Press Releases for the Psychedelics Industry

Psychedelics News

Press Releases

17 Feb 2021

Psyched Wellness Closes $6,603,000 Bought Deal Private Placement

Toronto, Ontario–(Newsfile Corp....

By Microdose

Press Releases

17 Feb 2021

Revive Therapeutics Acquires Unique Psilocybin Assets

TORONTO, Feb....

By Microdose

Press Releases

17 Feb 2021

MindMed’s LSD Neutralizer Study Begins

Potential Emergency Off-Switch for Psychedelic Assisted Therapies BASEL, SwitzerlandFeb....

By Microdose

Press Releases

17 Feb 2021

Mindset Pharma Announces U.S. Listing Application for OTCQB Venture Market

Toronto, Ontario–(Newsfile Corp....

By Microdose

Join Our Newsletter for Exclusive Updates, Stories, and More

Press Releases

16 Feb 2021

Field Trip Health Ltd. Reports Third Fiscal Quarter 2021 Financial Results

Q3 2021 patient services revenues of $316,329 represent a 235% increase over the previous quarter Field Trip continues to advance development of FT-104, a novel psychedelic molecule with pending patents...

By Microdose

Press Releases

16 Feb 2021

REPEAT — Pure Extracts Agrees to Licensing deal with Taste-T, LLC the US manufacturer of Fireball Cannabis Gummies

VANCOUVER, British Columbia, Feb....

By Microdose

Press Releases

16 Feb 2021

Entheon Biomedical Hires Chief Business Officer; Senior Pharma Executive Dr. Brian Jahns to Oversee Business Development

Vancouver, British Columbia–(Newsfile Corp....

By Microdose

Press Releases

16 Feb 2021

Cybin Inc. Releases Financial Highlights and Provides Business Update

Successful bought deal offering brings total capital raised to-date to approximately $90 million Increased patent applications filed to 10, covering novel molecules, delivery systems, deuterated tryptamines and phenethylamines Adelia Therapeutics...

By Microdose

Press Releases

16 Feb 2021

Pure Extracts Agrees to Licensing deal with Taste-T, LLC the US manufacturer of Fireball Cannabis Gummies

VANCOUVER, British Columbia, Feb....

By Microdose

Follow us on social

Latest News

Trump’s Psychedelic Fast-Track Order Changes the Timeline. It Also Redraws the Competitive Map.

AbbVie Withdraws Patent Challenge, Clearing Path for Enveric’s Psychedelic IP Strategy

Breaking: Enveric Reports New Mechanistic Data Supporting Non-Hallucinogenic Neuroplastogen Strategy

Professional Training in Psychedelic Medicine

Psychedelic medicine is reshaping the future of mental health care. From the power of microdosing LSD to the promise of MDMA in PTSD, the world of medical psychedelics offers transformative possibilities. Our comprehensive, CE-accredited course provides you with the knowledge and understanding you need to tap into this groundbreaking field.

WordPress Ads

No Result

View All Result